Phase II clinical trial of VP-16-213 (etoposide) administered orally in advanced ovarian cancer
Flemming Hansen, Inger Malthe, Hans KrogVolume:
36
Year:
1990
Language:
english
DOI:
10.1016/0090-8258(90)90144-a
File:
PDF, 233 KB
english, 1990